Literature DB >> 20864404

Imatinib treatment of metastatic GIST: don't stop (believing).

Michael C Heinrich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864404     DOI: 10.1016/S1470-2045(10)70225-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

Review 1.  The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy.

Authors:  Heikki Joensuu; Ronald P DeMatteo
Journal:  Annu Rev Med       Date:  2011-10-13       Impact factor: 13.739

Review 2.  Adjuvant treatment of GIST: patient selection and treatment strategies.

Authors:  Heikki Joensuu
Journal:  Nat Rev Clin Oncol       Date:  2012-04-24       Impact factor: 66.675

Review 3.  Predictive biomarkers: a paradigm shift towards personalized cancer medicine.

Authors:  Nicholas B La Thangue; David J Kerr
Journal:  Nat Rev Clin Oncol       Date:  2011-08-23       Impact factor: 66.675

4.  Cell biology: a key driver of therapeutic innovation.

Authors:  Oliver Hantschel; Giulio Superti-Furga
Journal:  J Cell Biol       Date:  2012-11-12       Impact factor: 10.539

Review 5.  Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

Authors:  Axel Schulenburg; Katharina Blatt; Sabine Cerny-Reiterer; Irina Sadovnik; Harald Herrmann; Brigitte Marian; Thomas W Grunt; Christoph C Zielinski; Peter Valent
Journal:  J Hematol Oncol       Date:  2015-02-25       Impact factor: 17.388

6.  Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumours.

Authors:  V R Bulusu; J Fullarton; M Leahy; C Morgan; A Rasheed; P Taniere; S Toh; M Verrill; J White; I Judson
Journal:  Br J Cancer       Date:  2013-08-20       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.